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 Abstract
A 32 year old woman with history of intravenous drug abuse with last reported use of heroin about a 
month prior, presented with fever for 1 week. She reported re-using the same needle and water for 
injections. Blood cultures grew Pseudomonas  luorescence in all four bottles. P.  luorescens is a gram 
negative rod that thrives in moist environments and can be dif icult to grow at standard incubation 
temperature. It is considered as a low virulent organism and is a rare cause of human infection. P. 
 luoresecence has rarely been reported to cause delayed bacteremia as in our patient. Our patient had 
resolution of bacteremia and symptoms following treatment with intravenous ceftazidime for two 
weeks.
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Introduction
 Pseudomonas  luorescens is an aerobic, gram negative psychrophilic bacterial rod that grows best 
º º º °
at temperatures of approximately 77 F--86 F (25 C-30 C). The identi ication of P.  luorescens can be 
°
dif icult due to poor growth at the standard hospital microbiology incubation temperature (36 C). (1,2) 
The bacteria typically thrive in moist environments (including water, soil, and foods) and are very 
infrequently implicated as a cause of human infections. In experimental studies on cultured human 
° °
pulmonary cells, the bacteria induce in lammatory mediators at 28 C and form bio ilm at 37 C that may 
contribute to its pathogenic potential.(3) We hereby report a case of P.  luorescens bacteremia in the 
setting of intravenous drug abuse.
 Case Report
 A 32 years old white female presented to the emergency department with high grade intermittent 
fever, chills, night sweats and low back pain for 1 week. She had recovered from an upper respiratory tract 
infection 3 weeks prior to presentation that was treated with prednisone and azithromycin. She reported 
use of intravenous heroin, using the same needle and water from a small plastic bottle lying in her car for 
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several days. Her last reported use of intravenous heroin was about a month prior to presentation. Her 
past medical history was signi icant for anxiety, post-traumatic stress disorder, May Heggling syndrome, 
chronic low back pain and endometriosis. She was unemployed, had no health insurance and lived with 
her husband. She smoked 1 pack of cigarettes a day for the past 10 years and denied drinking alcohol. Her 
family history was not contributory. 
o 
 Physical examination revealed temperature of 102 F and heart rate of 110 beats per minute on 
presentation. Skin exam showed few needle track marks over her both upper extremities. Rest of the 
physical examination was unremarkable. Laboratory investigations showed a white blood cell count of 
3 3
4500/mm , hemoglobin of 11.3 g/dL, and a platelet count of 69,000/mm . Basic metabolic panel and 
urinalysis were normal. Urine toxicology screen was negative for opiates and for other commonly tested 
illicit drugs. Serologies for HIV and Hepatitis C were negative. She was started on empiric antibiotic 
therapy with intravenous Vancomycin 1 gram every 12 hours and intravenous Ceftazidine 1 gram every 8 
hours. Blood cultures showed growth in all four bottles for Pseudomonas species. With the availability of 
preliminary blood culture results, Vancomycin was discontinued, Ceftazidime dose was increased to 2 
grams every 8 hours intravenously and intravenous Tobramycin was added at a dose of 60 mg every 8 
hours. Blood cultures  inally grew Pseudomonas  luorescence that was sensitive to Ceftazidime. A 
transesophageal echocardiography was performed that did not show any vegetations. MRI of her lumbar 
spine did not reveal any abnormality. Blood cultures repeated after 48 hours of antibiotic therapy 
showed no growth. On day 3 of antibiotic therapy, her fever resolved. With the availability of antibiotic 
sensitivity pattern for P.  luorescens, intravenous Tobramycin was stopped and she was continued on 
intravenous Ceftazidime at prior dosage and was discharged home on day 4. She completed a course of 
intravenous Ceftazidime for 2 weeks.
 She continues to remain asymptomatic. She was counselled to stop using intravenous drugs and 
was oﬀered social support.
Discussion
 P.  luorescens is an environmental microorganism that has been increasingly identi ied as a cause 
of nosocomial infections. It has been reported to cause occasional cases of transfusion-associated 
septicemia in blood recipients, including fatal reactions (4), and catheter-related bacteremia in patients 
with cancer.(5) Interestingly, it has been reported to cause substantially delayed bloodstream infections 
(i.e., up to 14 months) after exposure to a contaminated intravenous heparin  lush in patients with 
implantable venous ports.(1) The outbreak of P. luoresences in bone marrow transplant unit through 
contaminated drinking water has been reported in literature.(6) Although, the history obtained from 
patients abusing illicit drugs is often unreliable and the timing of last heroin use cannot be veri ied, the 
unusual  inding of bacteremia due to P.  luorescens in the setting of intravenous drug use makes this case 
unique. While the exact source of infection was unclear in our patient,  contaminated water used for drug 
injection was the most likely medium of acquisition of this rare microorganism. P.  luorescens has been 
decribed to thrive in moist environment. The mechanism of delayed bacertemia due to P.  luorescens is 
not quite well understood. However it is quite possible that percutaneous or blood stream inoculation of 
the organism may cause  transient bacteremia and potential seeding to distant organs. Due to its indolent 
growth patten, P.  luorescens may lead to delayed bacteremia. No case of P.  luorescens bacteremia related 
to  intravenous drug abuse has been reported in literature to date.
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